Company Overview of Caladrius Biosciences, Inc.
Hans S. Keirstead Ph.D.
Chief Science Officer, Senior Vice President of Research and President of Neostem Oncology, Caladrius Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 5 Board Members in 5 different organizations across 7 different industries.|
See Board Relationships
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships
President, Chief Executive Officer, and Director
University Of British Columbia
University of Cambridge
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Robin C. Stracey||Chief Executive Officer and Director|
Cesca Therapeutics Inc.
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|Andrey Semechkin Ph.D.||Co-Chairman and Chief Executive Officer|
International Stem Cell Corporation
|$246.1K||Compensation as of Fiscal Year 2014.|